{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:38:28Z","timestamp":1793695108169,"version":"4.5.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX001733"],"award-info":[{"award-number":["I01BX001733"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK097512"],"award-info":[{"award-number":["P30DK097512"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK093954"],"award-info":[{"award-number":["R01DK093954"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK127308"],"award-info":[{"award-number":["R01DK127308"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00125-026-06785-4","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:46:39Z","timestamp":1782513999000},"page":"2396-2407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-CoV-2 and diabetes: a post-pandemic reappraisal"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-9814","authenticated-orcid":false,"given":"Noora","family":"Said","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1344-4933","authenticated-orcid":false,"given":"Ian","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3279-5431","authenticated-orcid":false,"given":"Emily K.","family":"Anderson-Baucum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-8663","authenticated-orcid":false,"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"7","key":"6785_CR1","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","volume":"1","author":"B Schurink","year":"2020","unstructured":"Schurink B, Roos E, Radonic T et al (2020) Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 1(7):e290\u2013e299. https:\/\/doi.org\/10.1016\/S2666-5247(20)30144-0","journal-title":"Lancet Microbe"},{"issue":"8","key":"6785_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/diagnostics14080787","volume":"14","author":"L Alfieri","year":"2024","unstructured":"Alfieri L, Franceschetti L, Frisoni P et al (2024) Cardiac SARS-CoV-2 infection, involvement of cytokines in postmortem immunohistochemical study. Diagnostics (Basel) 14(8):787. https:\/\/doi.org\/10.3390\/diagnostics14080787","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"6785_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1681\/ASN.2020040432","volume":"31","author":"EA Farkash","year":"2020","unstructured":"Farkash EA, Wilson AM, Jentzen JM (2020) Ultrastructural evidence for direct renal infection with SARS-CoV-2. J Am Soc Nephrol 31(8):1683\u20131687. https:\/\/doi.org\/10.1681\/ASN.2020040432","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"6785_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/gutjnl-2020-321013","volume":"69","author":"L Lin","year":"2020","unstructured":"Lin L, Jiang X, Zhang Z et al (2020) Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 69(6):997\u20131001. https:\/\/doi.org\/10.1136\/gutjnl-2020-321013","journal-title":"Gut"},{"issue":"5","key":"6785_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2023.01.039","volume":"186","author":"GY Oudit","year":"2023","unstructured":"Oudit GY, Wang K, Viveiros A, Kellner MJ, Penninger JM (2023) Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic. Cell 186(5):906\u2013922. https:\/\/doi.org\/10.1016\/j.cell.2023.01.039","journal-title":"Cell"},{"issue":"15","key":"6785_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","volume":"69","author":"S Garg","year":"2020","unstructured":"Garg S, Kim L, Whitaker M et al (2020) Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep 69(15):458\u2013464. https:\/\/doi.org\/10.15585\/mmwr.mm6915e3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7821","key":"6785_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584(7821):430\u2013436. https:\/\/doi.org\/10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"issue":"10229","key":"6785_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"issue":"10","key":"6785_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","volume":"8","author":"N Holman","year":"2020","unstructured":"Holman N, Knighton P, Kar P et al (2020) Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 8(10):823\u2013833. https:\/\/doi.org\/10.1016\/S2213-8587(20)30271-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"13","key":"6785_CR10","doi-asserted-by":"publisher","first-page":"e028896","DOI":"10.1161\/JAHA.122.028896","volume":"12","author":"H Bashar","year":"2023","unstructured":"Bashar H, Kobo O, Khunti K et al (2023) Impact of the COVID-19 pandemic on diabetes-related cardiovascular mortality in the United States. J Am Heart Assoc 12(13):e028896. https:\/\/doi.org\/10.1161\/JAHA.122.028896","journal-title":"J Am Heart Assoc"},{"key":"6785_CR11","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.5888\/pcd18.210123","volume":"18","author":"L Kompaniyets","year":"2021","unstructured":"Kompaniyets L, Pennington AF, Goodman AB et al (2021) Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev Chronic Dis 18:E66. https:\/\/doi.org\/10.5888\/pcd18.210123","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"6785_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2337\/dc20-2260","volume":"44","author":"JM Gregory","year":"2021","unstructured":"Gregory JM, Slaughter JC, Duffus SH et al (2021) COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic\u2019s impact in type 1 and type 2 diabetes. Diabetes Care 44(2):526\u2013532. https:\/\/doi.org\/10.2337\/dc20-2260","journal-title":"Diabetes Care"},{"issue":"8","key":"6785_CR13","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.2337\/dc20-1088","volume":"43","author":"OA Ebekozien","year":"2020","unstructured":"Ebekozien OA, Noor N, Gallagher MP, Alonso GT (2020) Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S. Diabetes Care 43(8):e83\u2013e85. https:\/\/doi.org\/10.2337\/dc20-1088","journal-title":"Diabetes Care"},{"issue":"11","key":"6785_CR14","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.2337\/dc20-1321","volume":"43","author":"I Rabbone","year":"2020","unstructured":"Rabbone I, Schiaffini R, Cherubini V et al (2020) Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care 43(11):2870\u20132872. https:\/\/doi.org\/10.2337\/dc20-1321","journal-title":"Diabetes Care"},{"issue":"11","key":"6785_CR15","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.2337\/dc20-1551","volume":"43","author":"R Unsworth","year":"2020","unstructured":"Unsworth R, Wallace S, Oliver NS et al (2020) New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 43(11):e170\u2013e171. https:\/\/doi.org\/10.2337\/dc20-1551","journal-title":"Diabetes Care"},{"issue":"8","key":"6785_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2020.13445","volume":"324","author":"C Kamrath","year":"2020","unstructured":"Kamrath C, Monkemoller K, Biester T et al (2020) Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA 324(8):801\u2013804. https:\/\/doi.org\/10.1001\/jama.2020.13445","journal-title":"JAMA"},{"issue":"3","key":"6785_CR17","first-page":"177","volume":"121","author":"A Ansar","year":"2022","unstructured":"Ansar A, Livett T, Beaton W, Carrel AL, Bekx MT (2022) Sharp rise in new-onset pediatric diabetes during the COVID-19 pandemic. WMJ 121(3):177\u2013180","journal-title":"WMJ"},{"issue":"1","key":"6785_CR18","doi-asserted-by":"publisher","first-page":"2428067","DOI":"10.1080\/16549716.2024.2428067","volume":"17","author":"JS Wu","year":"2024","unstructured":"Wu JS, Huang KK (2024) Measuring influencing factors affecting mortality rates during the COVID-19 pandemic. Glob Health Action 17(1):2428067. https:\/\/doi.org\/10.1080\/16549716.2024.2428067","journal-title":"Glob Health Action"},{"issue":"11","key":"6785_CR19","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.2337\/dci20-0044","volume":"43","author":"LA DiMeglio","year":"2020","unstructured":"DiMeglio LA, Albanese-O\u2019Neill A, Munoz CE, Maahs DM (2020) COVID-19 and children with diabetes-updates, unknowns, and next steps: first, Do No extrapolation. Diabetes Care 43(11):2631\u20132634. https:\/\/doi.org\/10.2337\/dci20-0044","journal-title":"Diabetes Care"},{"issue":"10","key":"6785_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41574-024-01004-9","volume":"20","author":"C Debuysschere","year":"2024","unstructured":"Debuysschere C, Nekoua MP, Alidjinou EK, Hober D (2024) The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus. Nat Rev Endocrinol 20(10):588\u2013599. https:\/\/doi.org\/10.1038\/s41574-024-01004-9","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"6785_CR21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s42255-020-00281-8","volume":"2","author":"T Hollstein","year":"2020","unstructured":"Hollstein T, Schulte DM, Schulz J et al (2020) Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab 2(10):1021\u20131024. https:\/\/doi.org\/10.1038\/s42255-020-00281-8","journal-title":"Nat Metab"},{"issue":"1","key":"6785_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","volume":"27","author":"L Yang","year":"2020","unstructured":"Yang L, Han Y, Nilsson-Payant BE et al (2020) A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell 27(1):125-136 e127. https:\/\/doi.org\/10.1016\/j.stem.2020.06.015","journal-title":"Cell Stem Cell"},{"issue":"6","key":"6785_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2020.11.006","volume":"32","author":"KC Coate","year":"2020","unstructured":"Coate KC, Cha J, Shrestha S et al (2020) SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in \u03b2 cells. Cell Metab 32(6):1028-1040.e1024. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.006","journal-title":"Cell Metab"},{"issue":"6","key":"6785_CR24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","volume":"32","author":"I Kusmartseva","year":"2020","unstructured":"Kusmartseva I, Wu W, Syed F et al (2020) Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab 32(6):1041-1051 e1046. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.005","journal-title":"Cell Metab"},{"issue":"16","key":"6785_CR25","doi-asserted-by":"publisher","first-page":"e151551","DOI":"10.1172\/jci.insight.151551","volume":"6","author":"MMF Qadir","year":"2021","unstructured":"Qadir MMF, Bhondeley M, Beatty W et al (2021) SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes. JCI Insight 6(16):e151551. https:\/\/doi.org\/10.1172\/jci.insight.151551","journal-title":"JCI Insight"},{"issue":"2","key":"6785_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","volume":"3","author":"JA Muller","year":"2021","unstructured":"Muller JA, Gross R, Conzelmann C et al (2021) SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab 3(2):149\u2013165. https:\/\/doi.org\/10.1038\/s42255-021-00347-1","journal-title":"Nat Metab"},{"issue":"8","key":"6785_CR27","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","volume":"33","author":"CT Wu","year":"2021","unstructured":"Wu CT, Lidsky PV, Xiao Y et al (2021) SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment. Cell Metab 33(8):1565-1576.e1565. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.013","journal-title":"Cell Metab"},{"issue":"8","key":"6785_CR28","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","volume":"33","author":"X Tang","year":"2021","unstructured":"Tang X, Uhl S, Zhang T et al (2021) SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metab 33(8):1577-1591 e1577. https:\/\/doi.org\/10.1016\/j.cmet.2021.05.015","journal-title":"Cell Metab"},{"issue":"3","key":"6785_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2337\/db24-0816","volume":"74","author":"C Andrade Barboza","year":"2025","unstructured":"Andrade Barboza C, Gon\u00e7alves LM, Pereira E et al (2025) SARS-CoV-2 spike S1 subunit triggers pericyte and microvascular dysfunction in human pancreatic islets. Diabetes 74(3):355\u2013367. https:\/\/doi.org\/10.2337\/db24-0816","journal-title":"Diabetes"},{"issue":"8","key":"6785_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/biology14080981","volume":"14","author":"I Kotsiri","year":"2025","unstructured":"Kotsiri I, Xanthi M, Domazinaki CM, Magiorkinis E (2025) The role of viral infections in the immunopathogenesis of type 1 diabetes mellitus: a narrative review. Biology (Basel) 14(8):981. https:\/\/doi.org\/10.3390\/biology14080981","journal-title":"Biology (Basel)"},{"issue":"6","key":"6785_CR31","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s00125-025-06401-x","volume":"68","author":"SJ Richardson","year":"2025","unstructured":"Richardson SJ, Rodriguez-Calvo T, Laiho JE et al (2025) Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue. Diabetologia 68(6):1226\u20131241. https:\/\/doi.org\/10.1007\/s00125-025-06401-x","journal-title":"Diabetologia"},{"issue":"12","key":"6785_CR32","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","volume":"25","author":"K Vehik","year":"2019","unstructured":"Vehik K, Lynch KF, Wong MC et al (2019) Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med 25(12):1865\u20131872. https:\/\/doi.org\/10.1038\/s41591-019-0667-0","journal-title":"Nat Med"},{"issue":"11","key":"6785_CR33","doi-asserted-by":"publisher","first-page":"110508","DOI":"10.1016\/j.celrep.2022.110508","volume":"38","author":"V van der Heide","year":"2022","unstructured":"van der Heide V, Jangra S, Cohen P et al (2022) Limited extent and consequences of pancreatic SARS-CoV-2 infection. Cell Rep 38(11):110508. https:\/\/doi.org\/10.1016\/j.celrep.2022.110508","journal-title":"Cell Rep"},{"issue":"1","key":"6785_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-025-01074-z","volume":"31","author":"SF Mehdi","year":"2025","unstructured":"Mehdi SF, Qureshi MH, Pervaiz S et al (2025) Endocrine and metabolic alterations in response to systemic inflammation and sepsis: a review article. Mol Med 31(1):16. https:\/\/doi.org\/10.1186\/s10020-025-01074-z","journal-title":"Mol Med"},{"issue":"2","key":"6785_CR35","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.clinthera.2023.11.013","volume":"46","author":"V Limbachia","year":"2024","unstructured":"Limbachia V, Nunney I, Page DJ et al (2024) The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes. Clin Ther 46(2):e59\u2013e63. https:\/\/doi.org\/10.1016\/j.clinthera.2023.11.013","journal-title":"Clin Ther"},{"issue":"7","key":"6785_CR36","doi-asserted-by":"publisher","first-page":"e26714","DOI":"10.7759\/cureus.26714","volume":"14","author":"D Vedantam","year":"2022","unstructured":"Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK (2022) Stress-induced hyperglycemia: consequences and management. Cureus 14(7):e26714. https:\/\/doi.org\/10.7759\/cureus.26714","journal-title":"Cureus"},{"issue":"2","key":"6785_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/cc12514","volume":"17","author":"PE Marik","year":"2013","unstructured":"Marik PE, Bellomo R (2013) Stress hyperglycemia: an essential survival response! Crit Care 17(2):305. https:\/\/doi.org\/10.1186\/cc12514","journal-title":"Crit Care"},{"issue":"5","key":"6785_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s40618-022-01742-5","volume":"45","author":"A Basolo","year":"2022","unstructured":"Basolo A, Poma AM, Bonuccelli D et al (2022) Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response. J Endocrinol Invest 45(5):1021\u20131029. https:\/\/doi.org\/10.1007\/s40618-022-01742-5","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"6785_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ana.26318","volume":"91","author":"D Dodig","year":"2022","unstructured":"Dodig D, Tarnopolsky MA, Margeta M, Gordon K, Fritzler MJ, Lu JQ (2022) COVID-19-associated critical illness myopathy with direct viral effects. Ann Neurol 91(4):568\u2013574. https:\/\/doi.org\/10.1002\/ana.26318","journal-title":"Ann Neurol"},{"issue":"4","key":"6785_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","volume":"73","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu S, Liu H et al (2020) SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol 73(4):807\u2013816. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.002","journal-title":"J Hepatol"},{"issue":"674","key":"6785_CR41","doi-asserted-by":"publisher","first-page":"eabm9151","DOI":"10.1126\/scitranslmed.abm9151","volume":"14","author":"GJ Martinez-Colon","year":"2022","unstructured":"Martinez-Colon GJ, Ratnasiri K, Chen H et al (2022) SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci Transl Med 14(674):eabm9151. https:\/\/doi.org\/10.1126\/scitranslmed.abm9151","journal-title":"Sci Transl Med"},{"issue":"11","key":"6785_CR42","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.cmet.2021.09.009","volume":"33","author":"M Reiterer","year":"2021","unstructured":"Reiterer M, Rajan M, Gomez-Banoy N et al (2021) Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab 33(11):2174-2188 e2175. https:\/\/doi.org\/10.1016\/j.cmet.2021.09.009","journal-title":"Cell Metab"},{"issue":"1","key":"6785_CR43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13395-021-00266-5","volume":"11","author":"B Islam","year":"2021","unstructured":"Islam B, Ahmed M, Islam Z, Begum SM (2021) Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature. Skelet Muscle 11(1):10. https:\/\/doi.org\/10.1186\/s13395-021-00266-5","journal-title":"Skelet Muscle"},{"issue":"5","key":"6785_CR44","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","volume":"73","author":"M Iavarone","year":"2020","unstructured":"Iavarone M, D\u2019Ambrosio R, Soria A et al (2020) High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol 73(5):1063\u20131071. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.001","journal-title":"J Hepatol"},{"issue":"3","key":"6785_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","volume":"74","author":"T Marjot","year":"2021","unstructured":"Marjot T, Moon AM, Cook JA et al (2021) Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol 74(3):567\u2013577. https:\/\/doi.org\/10.1016\/j.jhep.2020.09.024","journal-title":"J Hepatol"},{"issue":"1","key":"6785_CR46","doi-asserted-by":"publisher","first-page":"e70156","DOI":"10.1002\/jmv.70156","volume":"97","author":"C Ko","year":"2025","unstructured":"Ko C, Cheng CC, Mistretta D et al (2025) SARS-CoV-2 productively infects human hepatocytes and induces cell death. J Med Virol 97(1):e70156. https:\/\/doi.org\/10.1002\/jmv.70156","journal-title":"J Med Virol"},{"issue":"1","key":"6785_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40842-021-00121-y","volume":"7","author":"AH Affinati","year":"2021","unstructured":"Affinati AH, Wallia A, Gianchandani RY (2021) Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases. Clin Diabetes Endocrinol 7(1):8. https:\/\/doi.org\/10.1186\/s40842-021-00121-y","journal-title":"Clin Diabetes Endocrinol"},{"issue":"6","key":"6785_CR48","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","volume":"3","author":"L Montefusco","year":"2021","unstructured":"Montefusco L, Ben Nasr M, D\u2019Addio F et al (2021) Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab 3(6):774\u2013785. https:\/\/doi.org\/10.1038\/s42255-021-00407-6","journal-title":"Nat Metab"},{"issue":"3","key":"6785_CR49","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2021.01.016","volume":"33","author":"DJ Drucker","year":"2021","unstructured":"Drucker DJ (2021) Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab 33(3):479\u2013498. https:\/\/doi.org\/10.1016\/j.cmet.2021.01.016","journal-title":"Cell Metab"},{"issue":"10","key":"6785_CR50","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.2337\/dc22-0396","volume":"45","author":"ES Keiner","year":"2022","unstructured":"Keiner ES, Slaughter JC, Datye KA, Cherrington AD, Moore DJ, Gregory JM (2022) COVID-19 exacerbates insulin resistance during diabetic ketoacidosis in pediatric patients with type 1 diabetes. Diabetes Care 45(10):2406\u20132411. https:\/\/doi.org\/10.2337\/dc22-0396","journal-title":"Diabetes Care"},{"issue":"3","key":"6785_CR51","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1210\/clinem\/dgab792","volume":"107","author":"A Laurenzi","year":"2022","unstructured":"Laurenzi A, Caretto A, Molinari C et al (2022) No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J Clin Endocrinol Metab 107(3):e1009\u2013e1019. https:\/\/doi.org\/10.1210\/clinem\/dgab792","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"6785_CR52","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1007\/s13300-021-01158-z","volume":"12","author":"A Goyal","year":"2021","unstructured":"Goyal A, Gupta Y, Kalaivani M, Bhatla N, Tandon N (2021) Impact of SARS-CoV-2 on progression of glycemic and cardiometabolic variables and changes in insulin indices: a longitudinal study. Diabetes Ther 12(11):3011\u20133023. https:\/\/doi.org\/10.1007\/s13300-021-01158-z","journal-title":"Diabetes Ther"},{"issue":"1","key":"6785_CR53","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1186\/s12889-023-15833-2","volume":"23","author":"TY Nour","year":"2023","unstructured":"Nour TY, Altintas KH (2023) Effect of the COVID-19 pandemic on obesity and its risk factors: a systematic review. BMC Public Health 23(1):1018. https:\/\/doi.org\/10.1186\/s12889-023-15833-2","journal-title":"BMC Public Health"},{"issue":"2","key":"6785_CR54","doi-asserted-by":"publisher","first-page":"368504211019854","DOI":"10.1177\/00368504211019854","volume":"104","author":"H Onyeaka","year":"2021","unstructured":"Onyeaka H, Anumudu CK, Al-Sharify ZT, Egele-Godswill E, Mbaegbu P (2021) COVID-19 pandemic: a review of the global lockdown and its far-reaching effects. Sci Prog 104(2):368504211019854. https:\/\/doi.org\/10.1177\/00368504211019854","journal-title":"Sci Prog"},{"issue":"1","key":"6785_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13690-021-00542-2","volume":"79","author":"S Drieskens","year":"2021","unstructured":"Drieskens S, Berger N, Vandevijvere S et al (2021) Short-term impact of the COVID-19 confinement measures on health behaviours and weight gain among adults in Belgium. Arch Public Health 79(1):22. https:\/\/doi.org\/10.1186\/s13690-021-00542-2","journal-title":"Arch Public Health"},{"key":"6785_CR56","doi-asserted-by":"publisher","first-page":"102345","DOI":"10.1016\/j.eclinm.2023.102345","volume":"66","author":"R Izzo","year":"2023","unstructured":"Izzo R, Pacella D, Trimarco V et al (2023) Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study. EClinicalMedicine 66:102345. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102345","journal-title":"EClinicalMedicine"},{"issue":"1","key":"6785_CR57","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41398-025-03485-2","volume":"15","author":"JP Yuan","year":"2025","unstructured":"Yuan JP, Borchers LR, Lee Y et al (2025) The effects of the COVID-19 pandemic on neurobiological functioning in adolescents. Transl Psychiatry 15(1):276. https:\/\/doi.org\/10.1038\/s41398-025-03485-2","journal-title":"Transl Psychiatry"},{"issue":"5","key":"6785_CR58","doi-asserted-by":"publisher","first-page":"e2025070849","DOI":"10.1542\/peds.2025-070849","volume":"156","author":"SH Woolf","year":"2025","unstructured":"Woolf SH (2025) The youth mental health crisis in the United States: epidemiology, contributors, and potential solutions. Pediatrics 156(5):e2025070849. https:\/\/doi.org\/10.1542\/peds.2025-070849","journal-title":"Pediatrics"},{"key":"6785_CR59","doi-asserted-by":"publisher","first-page":"104487","DOI":"10.1016\/j.ebiom.2023.104487","volume":"90","author":"JY Lu","year":"2023","unstructured":"Lu JY, Wilson J, Hou W et al (2023) Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. EBioMedicine 90:104487. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104487","journal-title":"EBioMedicine"},{"issue":"12","key":"6785_CR60","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2023.16348","volume":"330","author":"M Lugar","year":"2023","unstructured":"Lugar M, Eugster A, Achenbach P et al (2023) SARS-CoV-2 infection and development of islet autoimmunity in early childhood. JAMA J Am Med Assoc 330(12):1151\u20131160. https:\/\/doi.org\/10.1001\/jama.2023.16348","journal-title":"JAMA J Am Med Assoc"},{"issue":"6","key":"6785_CR61","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/jama.2024.11174","volume":"332","author":"N Friedl","year":"2024","unstructured":"Friedl N, Sporreiter M, Winkler C et al (2024) Progression from presymptomatic to clinical type 1 diabetes after COVID-19 infection. JAMA J Am Med Assoc 332(6):501\u2013502. https:\/\/doi.org\/10.1001\/jama.2024.11174","journal-title":"JAMA J Am Med Assoc"},{"issue":"5","key":"6785_CR62","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1056\/NEJMc2216477","volume":"389","author":"JP Krischer","year":"2023","unstructured":"Krischer JP, Lernmark A, Hagopian WA et al (2023) SARS-CoV-2 - No increased islet autoimmunity or type 1 diabetes in teens. N Engl J Med 389(5):474\u2013475. https:\/\/doi.org\/10.1056\/NEJMc2216477","journal-title":"N Engl J Med"},{"issue":"12","key":"6785_CR63","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.2337\/dc23-0936","volume":"46","author":"TYJ Hsieh","year":"2023","unstructured":"Hsieh TYJ, Chang R, Yong SB, Liao PL, Hung YM, Wei JC (2023) COVID-19 vaccination prior to SARS-CoV-2 infection reduced risk of subsequent diabetes mellitus: a real-world investigation using U.S. electronic health records. Diabetes Care 46(12):2193\u20132200. https:\/\/doi.org\/10.2337\/dc23-0936","journal-title":"Diabetes Care"},{"issue":"8","key":"6785_CR64","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S2213-8587(24)00159-1","volume":"12","author":"K Taylor","year":"2024","unstructured":"Taylor K, Eastwood S, Walker V et al (2024) Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people. Lancet Diabetes Endocrinol 12(8):558\u2013568. https:\/\/doi.org\/10.1016\/S2213-8587(24)00159-1","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6785_CR65","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.jvacx.2023.100336","volume":"14","author":"B Kowall","year":"2023","unstructured":"Kowall B, Kostev K, Landgraf R et al (2023) Diabetes incidence before and after COVID-19 vaccination - Results from the German Disease Analyzer database. Vaccine X 14:100336. https:\/\/doi.org\/10.1016\/j.jvacx.2023.100336","journal-title":"Vaccine X"},{"issue":"2","key":"6785_CR66","doi-asserted-by":"publisher","first-page":"e2255965","DOI":"10.1001\/jamanetworkopen.2022.55965","volume":"6","author":"AC Kwan","year":"2023","unstructured":"Kwan AC, Ebinger JE, Botting P, Navarrette J, Claggett B, Cheng S (2023) Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection. JAMA Netw Open 6(2):e2255965. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55965","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6785_CR67","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12902-023-01424-0","volume":"23","author":"AS Alsudais","year":"2023","unstructured":"Alsudais AS, Alkanani RS, Fathi AB et al (2023) Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports. BMC Endocr Disord 23(1):164. https:\/\/doi.org\/10.1186\/s12902-023-01424-0","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"6785_CR68","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2337\/dc24-1003","volume":"47","author":"R Wong","year":"2024","unstructured":"Wong R, Hall MA, Wiggen T et al (2024) Effect of SARS-CoV-2 infection on incident diabetes by viral variant: findings from the national COVID cohort collaborative (N3C). Diabetes Care 47(10):1846\u20131854. https:\/\/doi.org\/10.2337\/dc24-1003","journal-title":"Diabetes Care"},{"issue":"8","key":"6785_CR69","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMc2018688","volume":"383","author":"F Rubino","year":"2020","unstructured":"Rubino F, Amiel SA, Zimmet P et al (2020) New-onset diabetes in covid-19. N Engl J Med 383(8):789\u2013790. https:\/\/doi.org\/10.1056\/NEJMc2018688","journal-title":"N Engl J Med"},{"key":"6785_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.it.2025.10.010","volume":"47","author":"CM Miller","year":"2025","unstructured":"Miller CM, Moen JK, Iwasaki A (2025) The lingering shadow of epidemics: post-acute sequelae across history. Trends Immunol 47:9\u201318. https:\/\/doi.org\/10.1016\/j.it.2025.10.010","journal-title":"Trends Immunol"},{"issue":"2","key":"6785_CR71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/imj.16251","volume":"54","author":"S Tan","year":"2024","unstructured":"Tan S, Pryor AJG, Melville GW, Fischer O, Hewitt L, Davis KJ (2024) The lingering symptoms of post-COVID-19 condition (long-COVID): a prospective cohort study. Intern Med J 54(2):224\u2013233. https:\/\/doi.org\/10.1111\/imj.16251","journal-title":"Intern Med J"},{"issue":"4","key":"6785_CR72","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, Murray B, Varsavsky T et al (2021) Attributes and predictors of long COVID. Nat Med 27(4):626\u2013631. https:\/\/doi.org\/10.1038\/s41591-021-01292-y","journal-title":"Nat Med"},{"issue":"12","key":"6785_CR73","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.2337\/dbi20-0032","volume":"69","author":"EL Feldman","year":"2020","unstructured":"Feldman EL, Savelieff MG, Hayek SS, Pennathur S, Kretzler M, Pop-Busui R (2020) COVID-19 and diabetes: a collision and collusion of two diseases. Diabetes 69(12):2549\u20132565. https:\/\/doi.org\/10.2337\/dbi20-0032","journal-title":"Diabetes"},{"issue":"5","key":"6785_CR74","doi-asserted-by":"publisher","first-page":"102235","DOI":"10.1016\/j.dsx.2021.102235","volume":"15","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Misra A (2021) Post COVID-19 syndrome (\u201cLong COVID\u201d) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr 15(5):102235. https:\/\/doi.org\/10.1016\/j.dsx.2021.102235","journal-title":"Diabetes Metab Syndr"},{"key":"6785_CR75","doi-asserted-by":"publisher","first-page":"974540","DOI":"10.3389\/fendo.2022.974540","volume":"13","author":"MC Pelle","year":"2022","unstructured":"Pelle MC, Zaffina I, Provenzano M, Moirano G, Arturi F (2022) COVID-19 and diabetes-Two giants colliding: from pathophysiology to management. Front Endocrinol (Lausanne) 13:974540. https:\/\/doi.org\/10.3389\/fendo.2022.974540","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"6785_CR76","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1002\/jmv.27996","volume":"94","author":"M Rahmati","year":"2022","unstructured":"Rahmati M, Keshvari M, Mirnasuri S et al (2022) The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis. J Med Virol 94(11):5112\u20135127. https:\/\/doi.org\/10.1002\/jmv.27996","journal-title":"J Med Virol"},{"key":"6785_CR77","doi-asserted-by":"publisher","unstructured":"Rosenbauer J, Stahl-Pehe A, Schlesinger S, Kuss O (2023) Comments on Rahmati et al., The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol 95(1):e28272. https:\/\/doi.org\/10.1002\/jmv.28272","DOI":"10.1002\/jmv.28272"},{"issue":"6","key":"6785_CR78","doi-asserted-by":"publisher","first-page":"e2321281","DOI":"10.1001\/jamanetworkopen.2023.21281","volume":"6","author":"D D'Souza","year":"2023","unstructured":"D\u2019Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R (2023) Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Netw Open 6(6):e2321281. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.21281","journal-title":"JAMA Netw Open"},{"issue":"6","key":"6785_CR79","doi-asserted-by":"publisher","first-page":"e28833","DOI":"10.1002\/jmv.28833","volume":"95","author":"M Rahmati","year":"2023","unstructured":"Rahmati M, Yon DK, Lee SW et al (2023) New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: a systematic review and meta-analysis of cohort studies. J Med Virol 95(6):e28833. https:\/\/doi.org\/10.1002\/jmv.28833","journal-title":"J Med Virol"},{"issue":"1","key":"6785_CR80","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12916-022-02656-y","volume":"20","author":"T Zhang","year":"2022","unstructured":"Zhang T, Mei Q, Zhang Z et al (2022) Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med 20(1):444. https:\/\/doi.org\/10.1186\/s12916-022-02656-y","journal-title":"BMC Med"},{"key":"6785_CR81","doi-asserted-by":"publisher","first-page":"155330","DOI":"10.1016\/j.metabol.2022.155330","volume":"137","author":"H Lai","year":"2022","unstructured":"Lai H, Yang M, Sun M et al (2022) Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metab Clin Exp 137:155330. https:\/\/doi.org\/10.1016\/j.metabol.2022.155330","journal-title":"Metab Clin Exp"},{"key":"6785_CR82","doi-asserted-by":"publisher","first-page":"1429848","DOI":"10.3389\/fendo.2024.1429848","volume":"15","author":"J Zhou","year":"2024","unstructured":"Zhou J, Wang Y, Xu R (2024) Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 15:1429848. https:\/\/doi.org\/10.3389\/fendo.2024.1429848","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6785_CR83","doi-asserted-by":"publisher","first-page":"112417","DOI":"10.1016\/j.diabres.2025.112417","volume":"227","author":"E Cocking","year":"2025","unstructured":"Cocking E, Daher J, Alabbood M (2025) New-onset diabetes mellitus post COVID-19 infection: a systematic review and meta-analysis. Diabetes Res Clin Pract 227:112417. https:\/\/doi.org\/10.1016\/j.diabres.2025.112417","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6785_CR84","doi-asserted-by":"publisher","first-page":"2492211","DOI":"10.1080\/22221751.2025.2492211","volume":"14","author":"A El-Naas","year":"2025","unstructured":"El-Naas A, Hamad O, Nair S et al (2025) New onset of type 1 and type 2 diabetes post-COVID-19 infection: a systematic review. Emerg Microbes Infect 14(1):2492211. https:\/\/doi.org\/10.1080\/22221751.2025.2492211","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"6785_CR85","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/dom.14269","volume":"23","author":"T Sathish","year":"2021","unstructured":"Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P (2021) Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab 23(3):870\u2013874. https:\/\/doi.org\/10.1111\/dom.14269","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"6785_CR86","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.pcd.2022.05.009","volume":"16","author":"M Banerjee","year":"2022","unstructured":"Banerjee M, Pal R, Dutta S (2022) Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes 16(4):591\u2013593. https:\/\/doi.org\/10.1016\/j.pcd.2022.05.009","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"6785_CR87","doi-asserted-by":"publisher","first-page":"20191","DOI":"10.1038\/s41598-022-24185-7","volume":"12","author":"P Ssentongo","year":"2022","unstructured":"Ssentongo P, Zhang Y, Witmer L, Chinchilli VM, Ba DM (2022) Association of COVID-19 with diabetes: a systematic review and meta-analysis. Sci Rep 12(1):20191. https:\/\/doi.org\/10.1038\/s41598-022-24185-7","journal-title":"Sci Rep"},{"key":"6785_CR88","doi-asserted-by":"publisher","first-page":"1215879","DOI":"10.3389\/fendo.2023.1215879","volume":"14","author":"C Bellia","year":"2023","unstructured":"Bellia C, Andreadi A, D\u2019Ippolito I et al (2023) Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 14:1215879. https:\/\/doi.org\/10.3389\/fendo.2023.1215879","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6785_CR89","doi-asserted-by":"publisher","first-page":"1170156","DOI":"10.3389\/fpubh.2023.1170156","volume":"11","author":"J Li","year":"2023","unstructured":"Li J, Li Y, Wang Z, Liu N, He L, Zhang H (2023) Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front Public Health 11:1170156. https:\/\/doi.org\/10.3389\/fpubh.2023.1170156","journal-title":"Front Public Health"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06785-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06785-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06785-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:29:55Z","timestamp":1785472195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06785-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6785"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06785-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors acknowledge the support of the Indiana Diabetes Research Center, supported by NIH P30DK097512.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Work in the authors\u2019 laboratories was supported by NIH grants R01 DK093954 and DK127308 and U01DK127786 (to CE-M) and VA Merit Award I01BX001733 (to CE-M).","order":2,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"CE-M has served on advisory boards related to type 1 diabetes research clinical trial initiatives: Isla Technologies, DiogenyX, Neurodon, Sanofi; has received in-kind research support from BMS\u202f(access to\u202fcompounds for a BT1D-funded project); and received past Investigator-initiated grants:\u202fLilly Pharmaceuticals\u202fand\u202fAstellas Pharmaceuticals. CE-M has a patent (16\/291,668) for Extracellular Vesicle Ribonucleic Acid (RNA) Cargo as a Biomarker of Hyperglycaemia and Type 1 Diabetes, and CE-M has a provisional patent (63\/285,765) for Biomarker for Type 1 Diabetes (PDIA1 as a biomarker of beta cell stress). These activities have not dealt directly with topics covered in this manuscript. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"NS, IJ and EKA-B contributed to writing of the original draft, review and editing. CE-M contributed to conceptualisation, writing of the original draft, review, editing and supervision. All authors approved the version of the manuscript to be published.","order":4,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}